Consensus EPS · Q2 2026
$2.01
Consensus revenue · Q2 2026
$2.1B
Analysts
16
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 16 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $2.1B | $2.1B | $2.2B |
| EPS | $1.98 | $2.01 | $2.05 |
| EBITDA | $555.3M | $563.2M | $568.5M |
| EBIT | $276.5M | $280.5M | $283.1M |
| Net income | $389.7M | $393.6M | $397.5M |
- Revenue$2.1B
- EPS$2.01
- EBITDA$563.2M
- EBIT$280.5M
- Net income$393.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $2.1B | $2.1B | +0.8% | $2.09 | $1.87 | +12.0% |
- Q1 2026+0.8%+12.0%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Zimmer Biomet Holdings (ZBH) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 2 analysts.
- Low
- $83.00
- Consensus
- $96.57
- Median
- $94.00
- High
- $115.00
- Current
- $96.98
- Upside
- -0.4%
Upside calculated vs most recent trading price of $96.98.
Analyst ratings
Consensus: Hold — based on 42 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 9, 2026 | BMO Capital | downgrade | Outperform | Market Perform |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| May 28, 2026 | Citigroup | maintain | Neutral | Neutral |
| Apr 29, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Apr 29, 2026 | Truist Securities | maintain | Hold | Hold |
| Apr 29, 2026 | Stifel | maintain | Buy | Buy |
| Apr 29, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 29, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Apr 29, 2026 | Citigroup | maintain | Neutral | Neutral |
| Apr 29, 2026 | Barclays | maintain | Underweight | Underweight |
- Jul 9, 2026BMO CapitalMarket Perform
- Jul 6, 2026Evercore ISI GroupOutperform
- May 28, 2026CitigroupNeutral
- Apr 29, 2026Wells FargoEqual Weight
- Apr 29, 2026Truist SecuritiesHold
- Apr 29, 2026StifelBuy
- Apr 29, 2026JP MorganNeutral
- Apr 29, 2026CitizensMarket Outperform
- Apr 29, 2026CitigroupNeutral
- Apr 29, 2026BarclaysUnderweight
Frequently asked questions
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks4.22% TTM
- Dividend Profile0.99% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History1 split
How this company returns cash to shareholders — buybacks, dividends, and stock splits.